If the FDA grants Lecanemab full approval, medical experts say Medicaid and Medicare will likely cover it MORE ⬇️
The Food and Drug Administration is expected to give full approval to a drug called Lecanemab on July 6th.Dr. Zaldy Tan is the director of the Memory and Aging Program at Cedars-Sinai Medical Center in Los Angeles.Up until now, we only had therapies to help treat symptoms.
"The estimates are still preliminary, but the estimates are that the slowing is equivalent to about six months after 18 months of therapy," Dr. Tan said."So for some people, that six months is fairly modest and may not be noticeable. But for some people, the six months may mean being able to attend a wedding or attending a grandson's graduation or taking a trip."
However, Dr. Tan says it's only been effective in patients who have mild or moderate Alzheimer's Disease. "The reason why the FDA announcement about this medication is so important is because the center for Medicare and Medicaid, which is the largest insurer of older Americans, have stated that if this medication receives full FDA approval, that they are planning to cover it," Dr. Tan said.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Thousands Of Residents In The DC Region Are Losing MedicaidThousands of Medicaid patients across the D.C. region are losing their insurance. Many due to simple paperwork issues. Here's what's happening and what to do.
Weiterlesen »
Governor explains why Medicaid coverage of doulas was vetoed from budget; backers of the program reactOhio Governor Mike DeWine made dozens of line-item vetoes before signing the state’s $191 billion budget on Monday.
Weiterlesen »
New Bill Would Require Medicare to Cover 'Home Resiliency' Amid Worsening Climate Crisis“Climate justice is a matter of disability justice,' said Sen. Ed Markey. 'It's time that we guarantee that seniors and people with disabilities can safely weather the climate crisis.'
Weiterlesen »
FDA Gives The Okay For Abbott’s New Minimally Invasive PacemakerOn Wednesday, medtech giant Abbott announced that its new leadless pacemaker system, Aveir DR, has been approved by the FDA. This is the first time the FDA has given a thumbs up to a device of this type for two different chambers of the heart.
Weiterlesen »
FDA, FTC warn 6 companies allegedly selling delta-8 THC infused foods with confusing labelingThe FDA and Federal Trade Commission have issued warning letters to six companies it says are illegally selling copycat foods infused with delta-8 THC.
Weiterlesen »
InnovationRx: FDA OKs Abbott’s New PacemakerInnovationRx is your weekly digest of healthcare news. Sign up!
Weiterlesen »